BD Veritor™ System for Flu A+B Featuring Alverix Technology Receives Regulatory Approval in Japan
SAN JOSE, Calif.--(BUSINESS WIRE)--Alverix announced today that BD (Becton, Dickinson and Company) has received approval from the Japanese Ministry of Health, Labour, and Welfare (MHLW) for the BD Veritor™ System Flu A+B Test.
The BD Veritor System was developed by BD which collaborated with Alverix for the development of the digital reader which employs Alverix’s unique and proprietary near-patient testing platform. The BD Veritor System reader utilizes Alverix’s novel optoelectronic and signal detection technologies. The BD Veritor System delivers very good positive and negative percent agreement when measured against polymerase chain reaction (PCR) results, the highest sensitivity standard currently available. Following a simple, convenient procedure, objective test results are provided on an easy-to-read digital display. Alverix manufactures and supplies the BD Veritor System reader to BD.
The BD Veritor System was developed by BD which collaborated with Alverix for the development of the digital reader which employs Alverix’s unique and proprietary near-patient testing platform. The BD Veritor System reader utilizes Alverix’s novel optoelectronic and signal detection technologies. The BD Veritor System delivers very good positive and negative percent agreement when measured against polymerase chain reaction (PCR) results, the highest sensitivity standard currently available. Following a simple, convenient procedure, objective test results are provided on an easy-to-read digital display. Alverix manufactures and supplies the BD Veritor System reader to BD.